From July 1, 2022 to September 30, 2022, the company has repurchased 169,090 shares, representing 0.82% for KRW 2,231.28 million. With this, the company has completed the repurchase of 380,360 shares, representing 1.86% for KRW 4,984.4 million under the buyback announced on May 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22,150 KRW | -3.06% | +2.07% | +7.52% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.52% | 396M | |
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.